- Home
- ILMN vs ZBH Comparison
ILMN vs ZBH Comparison
Compare ILMN & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- ZBH
- Stock Information
- Founded
- ILMN 1998
- ZBH 1927
- Country
- ILMN United States
- ZBH United States
- Employees
- ILMN N/A
- ZBH N/A
- Industry
- ILMN Medical Specialities
- ZBH Industrial Specialties
- Sector
- ILMN Health Care
- ZBH Health Care
- Exchange
- ILMN Nasdaq
- ZBH Nasdaq
- Market Cap
- ILMN 23.6B
- ZBH 21.0B
- IPO Year
- ILMN 2000
- ZBH N/A
- Fundamental
- Price
- ILMN $136.01
- ZBH $104.43
- Analyst Decision
- ILMN Buy
- ZBH Hold
- Analyst Count
- ILMN 17
- ZBH 21
- Target Price
- ILMN $163.12
- ZBH $123.68
- AVG Volume (30 Days)
- ILMN 2.1M
- ZBH 1.5M
- Earning Date
- ILMN 02-06-2025
- ZBH 02-06-2025
- Dividend Yield
- ILMN N/A
- ZBH 0.92%
- EPS Growth
- ILMN N/A
- ZBH 132.72
- EPS
- ILMN N/A
- ZBH 5.26
- Revenue
- ILMN $4,390,000,000.00
- ZBH $7,595,500,000.00
- Revenue This Year
- ILMN N/A
- ZBH $4.76
- Revenue Next Year
- ILMN $4.05
- ZBH $4.56
- P/E Ratio
- ILMN N/A
- ZBH $19.87
- Revenue Growth
- ILMN N/A
- ZBH 4.35
- 52 Week Low
- ILMN $97.36
- ZBH $101.47
- 52 Week High
- ILMN $156.66
- ZBH $133.90
- Technical
- Relative Strength Index (RSI)
- ILMN 45.65
- ZBH 36.63
- Support Level
- ILMN $130.20
- ZBH $104.65
- Resistance Level
- ILMN $135.41
- ZBH $106.63
- Average True Range (ATR)
- ILMN 4.45
- ZBH 2.03
- MACD
- ILMN -0.50
- ZBH -0.28
- Stochastic Oscillator
- ILMN 31.73
- ZBH 19.30
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.